Boron neutron capture therapy assisted by boron-conjugated nanoparticles

Polymer Journal

Volumn 44, Issue 6, 2012, Pages 522-530

  Sumitani, Shogo ^a   Nagasaki, Yukio ^a,b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NATIONAL INSTITUTE FOR MATERIALS SCIENCE   (Japan)

Author keywords

biodistribution; boron neutron capture therapy; drug delivery systems; nanoparticle assisted BNCT; polymeric micelles

Indexed keywords

BIODISTRIBUTIONS; BORON NEUTRON CAPTURE THERAPY; DRUG DELIVERY SYSTEM; NANOPARTICLE-ASSISTED BNCT; POLYMERIC MICELLE;

BORON COMPOUNDS; COPOLYMERS; DRUG DELIVERY; ENCAPSULATION; HYDROGEN BONDS; MICELLES; NANOPARTICLES; NEUTRON IRRADIATION; NEUTRONS; PHYSIOLOGY; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; POLYMERS; STYRENE; TUMORS;

BORON;

EID: 84861920967     PISSN: 00323896     EISSN: 13490540     Source Type: Journal    
DOI: 10.1038/pj.2012.30     Document Type: Review

References (62)

1. Barth, R. F., Soloway, A. H., Fairchild, R. G. & Brugger, R. M. Boron neutron capture therapy of cancer: Realities and prospects. Cancer 70, 2995-3007 (1992).
2. Barth, R. F., Coderre, J. A., Vincente, G. H. & Blue, T. E. Boron neutron capture therapy of cancer: Current status and future property. Cli. Cancer Res. 11, 3987-4002 (2005). (Pubitemid 40791562)
3. Locher, G. L. Biological effects and therapeutic possibilities of neutrons. Am. J. Roentgenol Radium Ther. 36, 1-13 (1936).
4. Farr, L. E., Sweet, W. H., Robertson, J. S., Foster, C. G., Locksley, H. B., Sutherland, D. L., Mendelsohn, M. L. & Stickley, E. E. Neutron capture therapy with boron in the treatment of glioblastoma multiforme. Am. J. Roentgenol Radium Ther. Nucl. Med. 71, 279-291 (1954).
5. Godwin, J. T., Farr, L. E., Sweet, W. H. & Robertson, J. S. Pathological study of eight patients with glioblastoma multiforme treated by neutroncapture therapy using boron-10. Cancer 8, 601-615 (1955).
6. Asbury, A. K., Ojemann, Nielson, S. L. & Sweet, W. H. Neuropathological study of fourteen cases of malignant brain tumor treated by boron-10 slow neutron capture therapy. J. Neuropathol Exp. Neurol. 31, 278-303 (1972).
7. Knoth, W. H., Sauer, J. C., England, D. C., Hertler, W. R. & Murtterties, E. L. Chemistry of boranes. XIX. derivative chemistry of B10H10-2 and B12H12-2. J. Am. Chem. Soc. 86, 3973-3983 (1964).
8. Snyder, H. R., Reedy, A. J. & Lennarz, W. Synthesis of aromatic boronic acids. Aldehyde boronic acids and a boronic acid analog of tyrosine. J. Am. Chem. Soc. 80, 835-838 (1958).
9. Roberts, D. C., Suda, K., Samanen, J. & Kemp, D. S. Pluripotential amino acids. 1. (L)-p-dihydroxyborylphenylalanine (L-Bph) as a precursor of the L-Phe and L-Tyr containing peptides; specific tritiation of L-Phe containing peptides as a final step in synthesis. Tetrahedron Lett. 21, 3435-3438 (1989).
10. Soloway, A. H., Hatanaka, H. & Davis, M. A. Penetration of brain and brain tumor. VII. Tumor-binding sulfhydryl boron compounds. J. Med. Chem. 10, 714-717 (1967).
11. Hatanaka, H. A revised boron-neutron capture therapy for malignant brain tumors: II. Interim clinical result with the patients excluding previous treatments. J. Neurol. 209, 81-94 (1975).
12. Hatanaka, H. & Nakagawa, Y. Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy. Int. J. Radiat. Oncol. Biol. Phys. 28, 1061-1066 (1994). (Pubitemid 24118041)
13. Mishima, Y., Ichihashi, M., Hatta, S., Honda, C., Yamaura, K. & Nakagawa, T. New thermal neutron capture therapy for malignant melanoma: melanogenesis-seeking 10B molecule-melanoma cell interaction from in vitro to first clinical trial. Pigment. Cell. Res. 2, 226-234 (1989).
14. Gibson, C. R., Staubus, A. E., Barth, R. F., Yang, W., Kleinholz, N. M., Jones, R. B., Church, K. B. G., Tjarks, W. & Soloway, A. H. Electrospray ionization mass spectrometry coupled to reversed-phase ion-pair high-performance liquid chromatography for quantitation of sodium borocaptate and application to pharmacokinetic analysis. Anal. Chem. 74, 2394-2399 (2002). (Pubitemid 34526046)
15. Ichikawa, H., Taniguchi, E., Fujimoto, T. & Fukumori, Y. Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer. Appl. Radiat. Isot. 67, 111-114 (2009).
16. Wu, G. L., Barth, R. F., Yang, W., Lee, R., Tjarks, W., Backer, M. V. & Backer, J. M. Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy. Anticancer Agents Med. Chem. 6, 167-170 (2006).
17. Yanagie, H., Ogata, A., Sugiyama, H., Eriguchi, M., Takamoto, S. & Takahashi, H. Application of drug delivery system to boron neutron capture therapy for cancer. Expert Opin. Drug. Deliv. 5, 427-443 (2008). (Pubitemid 351721722)
18. Matsumura, Y. & Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer. Res. 46, 6387-6392 (1986). (Pubitemid 17221789)
19. Maeda, H., Sawa, T. & Konno, T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J. Control Release. 74, 47-61 (2001). (Pubitemid 32727608)
20. Barth, R. F., Adams, D. M., Soloway, A. H., Alam, F. & Darby, M. V. Boronated starburst dendrimer-monoclonal antibody immunoconjugates: Evaluation as a potential delivery system for neutron capture therapy. Bioconjug Chem. 5, 58-66 (1994). (Pubitemid 2043885)
21. Wu, G., Barth, R. F., Yang, W., Chatterjee, M., Tjarks, W., Ciesielski, M. J. & Fenstermaker, R. A. Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy. Bioconjug. Chem. 15, 185-194 (2004). (Pubitemid 38165994)
22. Gedda, L., Olsson, P., Ponten, J. & Carlsson, J. Development and in vitro studies of epidermal growth factor-dextran conjugates for boron neutron capture therapy. Bioconjug. Chem. 7, 584-591 (1996). (Pubitemid 26369623)
23. Meo, C. D., Panza, L., Capitani, D., Mannia, L., Banzato, A., Rondina, M., Renier, D., Rosato, A. & Crescenzi, V. Hyaluronan as Carrier of carboranes for tumor targeting in boron neutron capture therapy. Biomacromolecules 8, 552-559 (2007). (Pubitemid 46323272)
24. Mehta, S. C., Lai, J. C. K. & Lu, D. R. Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy J. Microencapsul. 13, 269-279 (1996). (Pubitemid 26150165)
25. Ishida, O., Maruyama, K., Tanahashi, H., Iwatsuru, M., Sasaki, K., Eriguchi, M. & Yanagie, H. Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo. Pharm. Res. 18, 1042-1048 (2001). (Pubitemid 32799953)
26. Maruyama, K., Ishida, O., Kasaoka, S., Takizawa, T., Utoguchi, N., Shinohara, M., Chiba, M., Kobayashi, H., Eriguchi, M. & Yanagie, H. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferring-PEG liposomes, for boron neutron-capture therapy (BNCT). J. Control. Release. 98, 195-207 (2004). (Pubitemid 38950731)
27. Yanagie, H., Maruyama, K., Takizawa, T., Ishida, O., Ogura, K., Matsumoto, T., Sakurai, Y., Kobayashi, T., Shinohara, A., Rant, J., Skvarc, J., Ilic, R., Kuhne, G., Chiba, M., Furuya, Y., Sugiyama, H., Hisa, T., Ono, K., Kobayashi, H. & Eriguchi, M. Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model. Biomed. Pharmacother. 60, 43-50 (2006). (Pubitemid 41821218)
28. Wagner, E., Curiel, D. & Cotton, M. Delivery of drugs, proteins and genes into cells using transferring as a ligand for receptor-mediated endocytosis. Adv. Drug. Deliv. Rev. 14, 113-135 (1994). (Pubitemid 24131676)
29. Feakes, D. A., Shelly, K. & Hawthorne, M. F. Selective boron delivery to murine tumors by lipophilic species incorporated in the membranes of unilamellar liposomes. Proc. Natl. Acad. Sci. USA 92, 1367-1370 (1995).
30. Miyajima, Y., Nakamura, H., Kuwata, Y., Lee, J. D., Masunaga, S., Ono, K. & Maruyama, K. Transferrin-loaded nido-carborane liposomes: tumor-targeting boron delivery system for neutron capture therapy. Bioconjug. Chem. 17, 1314-1320 (2006). (Pubitemid 44455341)
31. Li, T., Hamdi, J. & Hawthorne, M. F. Unilamellar liposomes with enhanced boron content. Bioconjug. Chem. 17, 15-20 (2006). (Pubitemid 43157580)
32. Lee, J. D., Ueno, M., Miyajima, Y. & Nakamura, H. Synthesis of boron cluster lipids: closo-dodecaborate as an alternative hydrophilic function of boronated liposomes for neutron capture therapy. Org. Lett. 9, 323-326 (2007).
33. Ueno, M., Ban, H. S., Nakai, K., Inomata, R., Kaneda, Y., Matsumura, A. & Nakamura, H. Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy. Bioorg. Med. Chem. 18, 3059-3065 (2010).
34. Kataoka, K., Harada, A. & Nagasaki, Y. Block copolymer micelles for drug delivery: design characterization and biological significance. Adv. Drug. Dliv. Rev. 47, 113-131 (2001). (Pubitemid 32209236)
35. Gaucher, G., Dufresne, M. H., Sant, V. P., Kang, N., Maysinger, D. & Leroux, J. C. Block copolymer micelles: preparation, characterization and application in drug delivery. J. Control Release 109, 169-199 (2005).
36. Verrechia, T., Spenlehauer, G., Bazile, D. V., Murry-Brelier, A., Archimbaud, Y. & Veillard, M. Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers. J. Control. Release 36, 49-61 (1995).
37. Hagan, S. A., Coombes, A. G. A., Garnett, M. C., Dunn, S. E., Davies, M. C., Illum, L., Davis, S. S., Harding, S. E., Purkiss, S. & Gellert, P. R. Polylactide-poly(ethylene glycol) copolymers as drug delivery systems. 1. characterization of water dispersible micelle-forming systems. Langmuir. 12, 2153-2161 (1996). (Pubitemid 126564672)
38. Yamamoto, Y., Nagasaki, Y., Kato, Y., Sugiyama, Y. & Kataoka, K. Long-circulating poly(ethylene glycol)-poly(D, L-lactide) block copolymer micelles with modulated surface charge. J. Control. Release. 77, 27-38 (2001). (Pubitemid 33022613)
39. Stefani, M., Coudane, J. & Vert, M. In vitro ageing and degradation of PEG-PLA diblock copolymer-based nanoparticles. Polym. Degrad. Stab. 91, 2554-2559 (2006). (Pubitemid 44331408)
40. Yang, L., Ghzaoui, A. E. & Li, S. In vitro degradation behavior of Poly(lactide)-Poly(ethylene glycol) block copolymer micelles in aqueous solution. Int. J. Pharm. 400, 96-103 (2010).
41. Kim, S., Shi, Y., Kim, J. Y., Park, K. & Cheng, J. X. Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle-cell interaction. Expert Opin. Drug. Deliv. 7, 49-62 (2010).
42. Chen, H., Kim, S., He, W., Wang, H., Low, P. S., Park, K. & Cheng, J. X. Fast release of lipophilic agents from circulation PEG-PDLLA micelles revealed by in vivo förster resonance energy transfer imaging. Langmuir. 24, 5213-5217 (2008).
43. Burt, H. M., Zhang, X., Toleikis, P., Embree, L. & Hunter, W. L. Development of copolymers of poly(D, L-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel. Colloids Surf. B. Biointerfaces 16, 161-171 (1999). (Pubitemid 29486803)
44. Diezi, T. A., Bae, Y. & Kwon, G. S. Enhanced Stability of PEG-block-poly(N-hexyl stearate L-aspartamide) micelles in the presence of serum proteins. Mol. Pharm. 7, 1355-1360 (2010).
45. Rösler, A., Vandermeulen, G. W. & Klok, H. A. Advanced drug delivery devices via selfassembly of amphiphilic block copolymers. Adv. Drug. Deliv. Rev. 53, 95-108 (2001). (Pubitemid 33152835)
46. O'Reilly, R. K., Hawker, C. J. & Wooley, K. L. Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility. Chem. Soc. Rev. 35, 1068-1083 (2006). (Pubitemid 44611720)
47. Shuai, X., Merdan, T., Schaper, A. K., Xi, F. & Kissel, T. Core-cross-linked polymeric micelles as paclitaxel carriers. Bioconjug. Chem. 15, 441-448 (2004). (Pubitemid 38657848)
48. Rijcken, C. J., Snel, C. J., Schiffelers, R. M., Nostrum, C. F. & Hennink, W. E. Hydrolysable core-crosslinked thermosensitive polymeric micelles: synthesis, characterization and in vivo studies. Biomaterials 28, 5581-5593 (2007). (Pubitemid 47599643)
49. Iijima, M., Nagasaki, Y., Okada, T., Kato, M. & Kataoka, K. Core-polymerized reactive micelles from heterotelechelic amphiphilic block copolymers. Macromolecules 32, 1140-1146 (1999).
50. Kim, J. H., Emoto, K., Iijima, M., Nagasaki, Y., Aoyagi, T., Okano, T., Sakurai, Y. & Kataoka, K. Core-stabilized polymeric micelle as potential drug carrier: increased solubilization of taxol. Polym. Adv. Technol. 10, 647-654 (1999). (Pubitemid 30509479)
51. Du, W., Nyström, A. M., Zhang, K., Leonard, J. R. & Wooley, K. L. 19F-and fluorescently labeled micelles as nanoscopic assemblies for chemotherapeutic delivery. Bioconjug. Chem. 19, 2492-2498 (2008).
52. Yokoyama, M., Okano, T., Sakurai, Y., Ekimoto, H., Shibazaki, C. & Kataoka, K. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res. 51, 3229-3236 (1991).
53. Yoo, H. S., Lee, E. A. & Park, T. G. Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkage. J. Control Release 82, 17-27 (2002). (Pubitemid 34775044)
54. Bae, Y., Fukushima, S., Harada, A. & Kataoka, K. Design of environment-sensitive supramolecular assemblies for intercellular drug delivery: polymeric micelles that are responsive to intracellular pH change. Angew. Chem. Int. Ed. Engl. 42, 4640-4643 (2003). (Pubitemid 37271305)
55. Kataoka, K., Matsumoto, T., Yokoyama, M., Okano, T., Sakurai, Y., Fukushima, S., Okamoto, K. & Kwon, G. S. Doxorubicin-loaded poly(ethylene glycol)-poly(b-benzyl-Laspartate) copolymer micelles: Their pharmaceutical characteristics and biological significance. J. Control Release 64, 143-153 (2000). (Pubitemid 30035315)
56. Lee, J., Cho, E. C. & Cho, K. Incorporation and release behavior of hydrophobic drug in functionalized poly(D, L-lactide)-block-poly(ethylene oxide) micelles. J. Control Release 94, 323-335 (2004). (Pubitemid 38117144)
57. Danquah, M., Fujiwara, T. & Mahato, R. I. Self-assembling Methoxypoly(ethylene glycol)-b-poly(carbonate-co-L-lactide) block copolymer for drug delivery. Biomaterials 31, 2358-2370 (2010).
58. Benhabbour, S. R., Parott, M. C., Gratton, E. A. & Adronov, A. Synthesis and properties of carborane-containing dendronized polymers. Macromolecules 40, 5678-5688 (2007). (Pubitemid 47280840)
59. Sumitani, S., Oishi, M. & Nagasaki, Y. Carborane confined nanoparticles for boron neutron capture therapy: improved stability, blood circulation time and tumor accumulation. React Funct. Polym. 71, 684-693 (2011).
60. Davidson, M. G., Hibbert, T. G., Howard, J. A. K., Mackinnon, A. & Wade, K. Definitive crystal structures of ortho-, meta-and para-carboranes: supramolecular structures directed solely by C-HyO hydrogen bonding to hmpa (hmpa1/4 hexamethylphosphoramide). Chem. Commun. 19, 2285-2286 (1996). (Pubitemid 126679248)
61. Sumitani, S., Oishi, M., Yaguchi, T., Murotani, H., Horiguchi, Y., Suzuki, M., Ono, K., Yanagie, H. & Nagasaki, Y. Pharmacokinetics of core-polymerized, boron-conjugated micelles designed for boron neutron capture therapy for cancer. Biomaterials 33, 3568-3577 (2012).
62. Lewinski, N., Colvin, V. & Drezek, R. Cytotoxicity of nanoparticles. Small 4, 26-49 (2008).